Cataract surgery with Hydrus microstent reduces IOP, medication use

Investigators evaluated the 2-year efficacy and safety of cataract surgery with the Hydrus microstent (Ivantis) implantation.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553